Relapsed and Bortezomib Refractory Multiple Myeloma
1 clinical trials · Condition
◉ Watch Relapsed and Bortezomib Refractory Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma (NCT01083602) | Novartis Pharmaceuticals | 2010-06-01 |
Track Relapsed and Bortezomib Refractory Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.